Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

Publisher Name :
Date: 13-Nov-2018
No. of pages: 46
Inquire Before Buying

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018, provides an overview of the Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline landscape.

Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands and painful swallowing. Treatment includes antiviral medications.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Herpes Labialis (Oral Herpes) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Labialis (Oral Herpes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 3, 1, 3 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Herpes Labialis (Oral Herpes) (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Herpes Labialis (Oral Herpes) (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Herpes Labialis (Oral Herpes) (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Herpes Labialis (Oral Herpes) (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Herpes Labialis (Oral Herpes) (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2018

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Herpes Labialis (Oral Herpes) - Overview
Herpes Labialis (Oral Herpes) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Herpes Labialis (Oral Herpes) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development
AiCuris GmbH & Co KG
Beech Tree Labs Inc
NanoViricides Inc
Shulov Innovative Science Ltd
Herpes Labialis (Oral Herpes) - Drug Profiles
Aspidasept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
B-220 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BTL-TMLHSV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ethamsylate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
herpes simplex virus [type 1, 2] vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pritelivir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PRV-300 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Herpes Labialis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZEP-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Herpes Labialis (Oral Herpes) - Dormant Projects
Herpes Labialis (Oral Herpes) - Discontinued Products
Herpes Labialis (Oral Herpes) - Product Development Milestones
Featured News & Press Releases
Aug 23, 2017: AiCuris Announces Final Patient Treated in Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Apr 04, 2013: Beech Tree Labs Successfully Completes IND Phase I/IIa Oral Herpes Clinical Trial
Nov 05, 2010: AiCuris to Present Preclinical And Phase I Data Of Anti-HSV Drug AIC316 At Antivirals Congress
Sep 14, 2010: Beech Tree Labs Initiates Phase I/IIa Oral Herpes Trial
Jul 07, 2010: Beech Tree Labs Wins FDA Approval For Oral Herpes IND Application
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Herpes Labialis (Oral Herpes), H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Herpes Labialis (Oral Herpes) - Pipeline by AiCuris GmbH & Co KG, H2 2018
Herpes Labialis (Oral Herpes) - Pipeline by Beech Tree Labs Inc, H2 2018
Herpes Labialis (Oral Herpes) - Pipeline by NanoViricides Inc, H2 2018
Herpes Labialis (Oral Herpes) - Pipeline by Shulov Innovative Science Ltd, H2 2018
Herpes Labialis (Oral Herpes) - Dormant Projects, H2 2018
Herpes Labialis (Oral Herpes) - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Herpes Labialis (Oral Herpes), H2 2018 7
Number of Products under Development by Companies, H2 2018 8
Number of Products by Targets, H2 2018 13
Number of Products by Stage and Targets, H2 2018 13
Number of Products by Mechanism of Actions, H2 2018 15
Number of Products by Stage and Mechanism of Actions, H2 2018 15
Number of Products by Routes of Administration, H2 2018 17
Number of Products by Stage and Routes of Administration, H2 2018 17
Number of Products by Molecule Types, H2 2018 19
Number of Products by Stage and Molecule Types, H2 2018 19
  • Global and Chinese Metronidazole Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 139
    The 'Global and Chinese Metronidazole Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Metronidazole industry with a focus on the Chinese market. The report provides key statistics on the market status of the Metronidazole manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition,......
  • Global and Chinese Acinetobacter Infections Treatment Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Acinetobacter Infections Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Acinetobacter Infections Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Acinetobacter Infections Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report prov......
  • Global and Chinese Cephalosporin Drugs Industry, 2018 Market Research Report
    Published: 13-Dec-2018        Price: US 3000 Onwards        Pages: 142
    The 'Global and Chinese Cephalosporin Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cephalosporin Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cephalosporin Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry includi......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ampicillin Market 2018, Forecast to 2023
    Published: 13-Dec-2018        Price: US 4880 Onwards        Pages: 129
    Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol). Scope of the Report: This report focuses on the Ampicillin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, t......
  • Global Ampicillin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Dec-2018        Price: US 3480 Onwards        Pages: 135
    Ampicillin is semisynthetic penicillin and a ß-lactam antibiotic, with Antimicrobial Spectrum of Effective against both Gram-positive (similar to benzylpenicillin) and Gram-negative bacteria (similar to tetracyclines and chloramphenicol). Scope of the Report: This report focuses on the Ampicillin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, t......
  • Global Drugs for Toxoplasmosis Market Research Report 2012-2023
    Published: 12-Dec-2018        Price: US 3420 Onwards        Pages: 86
    Summary The global Drugs for Toxoplasmosis market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regional market. Products mentioned......
  • Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Research Report 2012-2023
    Published: 12-Dec-2018        Price: US 4200 Onwards        Pages: 113
    Summary The global Drugs for Vancomycin-Resistant Enterococcus Faecium market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regiona......
  • Global and Chinese Sepsis Partnering Industry, 2018 Market Research Report
    Published: 09-Dec-2018        Price: US 3000 Onwards        Pages: 146
    The 'Global and Chinese Sepsis Partnering Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Sepsis Partnering industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sepsis Partnering manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its......
  • Global and Chinese Cefazolin Sodium Industry, 2018 Market Research Report
    Published: 08-Dec-2018        Price: US 3000 Onwards        Pages: 148
    The 'Global and Chinese Cefazolin Sodium Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cefazolin Sodium industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cefazolin Sodium manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its de......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs